Generated: May 29, 2017
Which drugs does patent 8,518,987 protect, and when does it expire?
|Title:||Pseudopolymorphic forms of a HIV protease inhibitor|
|Abstract:||New pseudopolymorphic forms of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl (1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypr- opylcarbamate and processes for producing them are disclosed.|
|Inventor(s):||Vermeersch; Hans Wim Pieter (Ghent, BE), Thone; Daniel Joseph Christiaan (Beerse, BE), Janssens; Luc Donne Marie-Louise (Malle, BE), Wigerinck; Piet Tom Bert Paul (Terhagen, BE)|
|Assignee:||Janssen R&D Ireland (Little Island, Co. Cork, IE)|
Patent Claim Types:|
see list of patent claims
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
|TABLET;ORAL||021976-004||Dec 18, 2008||RX||Yes||No||8,518,987*PED||► Subscribe||Y|
|TABLET;ORAL||021976-005||Dec 18, 2008||RX||Yes||No||8,518,987*PED||► Subscribe||Y|
|TABLET;ORAL||021976-001||Jun 23, 2006||DISCN||Yes||No||8,518,987*PED||► Subscribe||Y|
|TABLET;ORAL||021976-003||Oct 21, 2008||DISCN||Yes||No||8,518,987*PED||► Subscribe||Y|
|TABLET;ORAL||021976-002||Feb 25, 2008||RX||Yes||No||8,518,987*PED||► Subscribe||Y|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|02076929||May 16, 2002|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.